GAMMA Investing’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$108K Buy
6,565
+70
+1% +$1.15K ﹤0.01% 1752
2026
Q1
$106K Buy
6,495
+1,782
+38% +$27.9K ﹤0.01% 1628
2025
Q4
$70K Buy
4,713
+2,812
+148% +$39.7K ﹤0.01% 1839
2025
Q3
$24.4K Sell
1,901
-1,198
-39% -$16K ﹤0.01% 2423
2025
Q2
$47K Sell
3,099
-3,402
-52% -$53.1K ﹤0.01% 1981
2025
Q1
$109K Buy
6,501
+4,453
+217% +$82K 0.01% 1182
2024
Q4
$38.6K Sell
2,048
-2,245
-52% -$43.3K ﹤0.01% 1851
2024
Q3
$80.7K Buy
4,293
+613
+17% +$11.7K 0.01% 1144
2024
Q2
$69.5K Buy
3,680
+1,271
+53% +$21.7K 0.01% 983
2024
Q1
$39.1K Buy
2,409
+50
+2% +$732 0.01% 1194
2023
Q4
$33K Buy
+2,359
New +$29.8K 0.01% 1172

Other funds holding SEM

GAMMA Investing's SEM Position: Q2 2026 in Review

GAMMA Investing increased its Select Medical (SEM) stake by 1.1% in Q2 2026, buying an estimated $1.15K and bringing the position to 6,565 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

GAMMA Investing first reported a position in SEM in Q4 2023 and has held it in 11 quarters since. The position peaked at $109K in Q1 2025. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • GAMMA Investing held 6,565 shares of Select Medical worth $108K as of Q2 2026.
  • GAMMA Investing bought 70 Select Medical shares in Q2 2026, an estimated $1.15K.
  • Select Medical made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #1752 holding.
  • GAMMA Investing first reported a position in Select Medical in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Select Medical position peaked at $109K in Q1 2025.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.